Susan Kadis at the Health Committee

I may be wrong, but it seems to me that a lot of the issues with post-market surveillance, from your perspective, could be addressed, probably from both perspectives, at the earlier stage. In other words, the post-market surveillance part of that process is actually going to be solving problems and difficulties that could have been dealt with at an earlier stage.